IBUPROFEN Immediate Release 200 mg/1
IBUPROFEN · TABLET, COATED · Strides Pharma Inc
No Recall History
Plain English
IBUPROFEN Immediate Release is a tablet, coated containing ibuprofen at 200 mg/1, taken oral. Manufactured by Strides Pharma Inc.
Key Facts
- Brand Name
- IBUPROFEN Immediate Release
- Generic Name
- IBUPROFEN
- NDC Code (Product)
59556-857- Manufacturer
- Strides Pharma Inc
- Strength
- 200 mg/1
- Dosage Form
- TABLET, COATED
- Route
- ORAL
- Marketing Status
- Application #
- ANDA079129
- Drug Class
- Nonsteroidal Anti-inflammatory Drug [EPC]
- Marketing Start
- 03/18/2022
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
drug ineffective15,478 reports
pain14,872 reports
fatigue14,245 reports
nausea13,252 reports
headache11,914 reports
arthralgia10,747 reports
dyspnoea10,354 reports
vomiting9,798 reports
diarrhoea9,539 reports
rash8,899 reports
Frequently Asked Questions
What is IBUPROFEN Immediate Release used for?
IBUPROFEN Immediate Release contains IBUPROFEN. It is a tablet, coated taken oral. Consult your doctor for specific uses.
Is IBUPROFEN Immediate Release a controlled substance?
IBUPROFEN Immediate Release is not classified as a controlled substance by the DEA.
What is the generic name for IBUPROFEN Immediate Release?
The generic name for IBUPROFEN Immediate Release is IBUPROFEN. There are 12 other brand versions of IBUPROFEN.
What is the NDC code for IBUPROFEN Immediate Release 200 mg/1?
The NDC (National Drug Code) for IBUPROFEN Immediate Release 200 mg/1 is 59556-857, listed by Strides Pharma Inc.